Advanced Medical Solutions Group plc (LON:AMS – Get Free Report)’s stock price reached a new 52-week high on Wednesday . The company traded as high as GBX 282 and last traded at GBX 280, with a volume of 1107860 shares changing hands. The stock had previously closed at GBX 280.
Wall Street Analysts Forecast Growth
A number of research analysts have recently issued reports on the stock. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a GBX 260 price objective on shares of Advanced Medical Solutions Group in a research report on Thursday, April 9th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a GBX 275 target price on shares of Advanced Medical Solutions Group in a research report on Friday, June 26th. Finally, Berenberg Bank restated a “buy” rating and issued a GBX 300 target price on shares of Advanced Medical Solutions Group in a research note on Tuesday, May 19th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, Advanced Medical Solutions Group currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 270.25.
Get Our Latest Report on Advanced Medical Solutions Group
Advanced Medical Solutions Group Trading Up 0.1%
About Advanced Medical Solutions Group
AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.
Featured Articles
- Five stocks we like better than Advanced Medical Solutions Group
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for Advanced Medical Solutions Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Solutions Group and related companies with MarketBeat.com's FREE daily email newsletter.
